Primer: GenFleet Therapeutics (GENFL12 HK) - Sep 2025
GenFleet Therapeutics is a clinical-stage biopharmaceutical company with a strong focus on developing novel therapies in oncology and...
106 Views
𝛼SK or SearchENTITY
Genfleet Therapeutics (2595 HK)
Genfleet Therapeutics (2595 HK)
38
Analysis
Health Care • China
Genfleet Therapeutics is a biopharmaceutical company focused on developing innovative treatments for oncology, including various solid tumors, and autoimmune and inflammatory diseases. The company's pipeline includes products like GFH925 (fulzerasib) for advanced non-small cell lung cancer and GFH375, a KRAS G12C inhibitor. Genfleet Therapeutics was incorporated in 2017 and is headquartered in Shanghai, China.
morex